Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease

NCT07384897 is registered in ClinicalTrials.gov with Université Catholique de Louvain as lead sponsor.

NCT NCT07384897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07384897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease
Lead sponsor
Université Catholique de Louvain
Phase
Not applicable
Overall status
Recruiting
Start date
February 17, 2025
Completion date
February 17, 2032
Enrollment
425 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease, immune dysregulation, immunotherapy resistance, lung cancer (diagnosis), sarcoidosis